Status:

COMPLETED

Effect of Granisetron on Morphine Induced Pruritus in Cesarean Section

Lead Sponsor:

Assiut University

Conditions:

Pruritus

Eligibility:

FEMALE

20-40 years

Phase:

PHASE2

Brief Summary

Neuraxial anesthesia, which includes epidural anesthesia and intrathecal anesthesia, is a frequent anesthetic approach for caesarean delivery and other lower abdominal and lower limb anesthetic proced...

Detailed Description

The study will be carried on 40 parturients scheduled for elective cesarean section (CS) under intrathecal anesthesia. They will be randomly allocated into two equal groups of 20 parturients each: Gr...

Eligibility Criteria

Inclusion

  • Parturients of American Society of Anesthesiologists (ASA) class I or II physical status.
  • Age: 20-40 years.
  • At term gestation (≥ 37 weeks) with a singleton uncomplicated pregnancy.
  • Elective cesarean delivery under intrathecal anesthesia.

Exclusion

  • Parturient refusal.
  • Significant organ dysfunctions (e.g., cardiac, respiratory, renal, or liver disorders).
  • Morbid obesity (BMI \>35).
  • Parturients with known hypersensitivity to granisetron, morphine or amide local anesthetics.
  • Parturients with pruritogenic systemic disease.
  • A coexisting skin disorder or preexisting pregnancy induced pruritus.
  • Parturients with any contraindication for intrathecal anesthesia, e.g. coagulopathy.
  • Emergency cesarean section.
  • Psychiatric disorders.
  • Fetal abnormalities.
  • Failed or unsatisfactory intrathecal block.

Key Trial Info

Start Date :

June 1 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 30 2020

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT03483870

Start Date

June 1 2018

End Date

October 30 2020

Last Update

September 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Assiut University Hospital

Asyut, Egypt